Australia markets closed

Lumos Diagnostics Holdings Limited (LDX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0360-0.0020 (-5.26%)
At close: 04:10PM AEST

Lumos Diagnostics Holdings Limited

100 Albert Road
Level 4 South Melbourne
Melbourne, VIC 3205
Australia
61 3 9087 1598
https://lumosdiagnostics.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Samuel LanyonExecutive Chairman166.9kN/AN/A
Mr. Douglas WardCEO, MD & Director910.8kN/AN/A
Mr. Barrie LambertChief Financial Officer556.62kN/AN/A
Dr. Sacha Dopheide Ph.D.Chief Technology OfficerN/AN/AN/A
Ms. Jennifer ChristiansenVice President of Corporate Marketing & CommunicationsN/AN/AN/A
Ms. Sarah GlubkaSenior Director of Human ResourcesN/AN/AN/A
Mr. Paul KaseSenior Vice President of Commercial OperationsN/AN/AN/A
Ms. Tracy Weimar BA, MBACompany SecretaryN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Lumos Diagnostics Holdings Limited, a contract research and development company, develops, manufactures, and commercializes rapid point-of-care (POC) diagnostic products for diagnosis and management of infectious diseases in the United States and Australia. The company's products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.

Corporate governance

Lumos Diagnostics Holdings Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.